Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunshine Lake Pharma CoHKSE:06887 +1.87%15 Market Cap is HK$29,814 Mil as of Aug. 21, 2026. GuruFocus rates HKSE:06887 with a GF Score™ of 15/100. The stock has 2 warning signs investors should review. Among 1,021 Drug Manufacturers companies, Sunshine Lake Pharma Co ranks better than 90.3% on this metric.
Sunshine Lake Pharma Co's quarterly market cap
stayed the same
from Dec. 2024 (HK$0 Mil) to Jun. 2025 (HK$0 Mil) but then
increased
from Jun. 2025 (HK$0 Mil) to Dec. 2025 (HK$26,274 Mil).
Sunshine Lake Pharma Co's annual market cap
stayed the same
from Dec. 2023 (HK$0 Mil) to Dec. 2024 (HK$0 Mil) but then
increased
from Dec. 2024 (HK$0 Mil) to Dec. 2025 (HK$26,274 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sunshine Lake Pharma Co's Enterprise Value for Today is HK$33,362 Mil.
Sunshine Lake Pharma Co (HKSE:06887) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sunshine Lake Pharma Co Market Cap Related Terms
Sunshine Lake Pharma Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sunshine Lake Pharma Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunshine Lake Pharma Co Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sunshine Lake Pharma Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Sunshine Lake Pharma Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sunshine Lake Pharma Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunshine Lake Pharma Co (HKSE:06887) has a Market Cap of HK$29,814 Mil as of Aug. 21, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sunshine Lake Pharma Co and its competitors. According to the industry distribution chart, Sunshine Lake Pharma Co ranks #99 out of 1021 companies in the Drug Manufacturers industry, placing it in the top 9.7%.
Is Sunshine Lake Pharma Co's Market Cap too high?
Sunshine Lake Pharma Co's current Market Cap is HK$29,814 Mil. Based on the distribution chart, Sunshine Lake Pharma Co ranks #99 out of 1021 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sunshine Lake Pharma Co has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Sunshine Lake Pharma Co's Market Cap compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sunshine Lake Pharma Co ranks #99 out of 1021 companies for Market Cap. This places Sunshine Lake Pharma Co in the top 10% of its industry — outperforming the majority of peers. The industry median Market Cap is 228.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 228.50, based on 1,021 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sunshine Lake Pharma Co and its competitors. For the Drug Manufacturers industry, the median Market Cap is 228.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunshine Lake Pharma Co's current Market Cap is HK$29,814 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Lake Pharma Co stock overvalued right now?
Sunshine Lake Pharma Co (HKSE:06887) has a current Market Cap of HK$29,814 Mil. The current Market Cap is HK$29,814 Mil. Sunshine Lake Pharma Co's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Sunshine Lake Pharma Co (HKSE:06887), the current Market Cap is HK$29,814 Mil as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sunshine Lake Pharma Co Ltd is a vertically integrated pharmaceutical company principally engaged in the research and development, manufacturing and sales of pharmaceuticals. It is focused on therapeutic areas of infectious diseases, chronic diseases and oncology. The company's revenue is mainly derived from sales of pharmaceutical products to distributors in the PRC.
15GF Score
Get the complete analysis for HKSE:06887
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06887 has been successfully added to your 
